| |
 |
|
Class Information
Number: 424/277.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Cancer cell or component thereof
Description: Subject matter involving a cancer cell or a component of a cancer cell.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7402317 |
Anti-cancer vaccine |
Jul. 22, 2008 |
| 7393921 |
Prostate-specific polypeptide pamp and encoding nucleic acid molecules |
Jul. 1, 2008 |
| 7387271 |
Immunostimulatory combinations |
Jun. 17, 2008 |
| 7368119 |
Compositions and methods for WT1 specific immunotherapy |
May. 6, 2008 |
| 7364741 |
Peptides of human Papilloma virus for use in human T cell response inducing compositions |
Apr. 29, 2008 |
| 7361360 |
Method of treating cancer cells to create a modified cancer cell that provokes an immunogenic response |
Apr. 22, 2008 |
| 7361346 |
Therapeutic compositions that produce an immune response |
Apr. 22, 2008 |
| 7355011 |
Biological products |
Apr. 8, 2008 |
| 7355012 |
Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells |
Apr. 8, 2008 |
| 7329410 |
Compositions and method for WT1 specific immunotherapy |
Feb. 12, 2008 |
| 7326767 |
Immunotherapeutic methods using epitopes of WT-1 and GATA-1 |
Feb. 5, 2008 |
| 7323181 |
Compositions and methods for WT1 specific immunotherapy |
Jan. 29, 2008 |
| 7317086 |
Basal cell carcinoma tumor suppressor protein |
Jan. 8, 2008 |
| 7306797 |
Use of a compound antagonist of ESM-1 protein for producing a medicine for treating cancer |
Dec. 11, 2007 |
| 7300655 |
Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof |
Nov. 27, 2007 |
| 7285282 |
Mucin peptide with immunoenhancing properties |
Oct. 23, 2007 |
| 7279156 |
Apoptotic entities for use in treatment of endothelium dysfunction disorders |
Oct. 9, 2007 |
| 7264820 |
Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokline |
Sep. 4, 2007 |
| RE39789 |
Tumor therapy |
Aug. 21, 2007 |
| 7252825 |
MAGE-3 peptides presented by HLA class II molecules |
Aug. 7, 2007 |
| 7252829 |
HLA binding peptides and their uses |
Aug. 7, 2007 |
| 7247703 |
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
Jul. 24, 2007 |
| 7247310 |
Tumor vaccines |
Jul. 24, 2007 |
| 7241441 |
Microorganism Pediococcus pentosaceus EROM101, having immune enhancement, anticancer and antimicrobial activities |
Jul. 10, 2007 |
| 7238360 |
Alteration of cell membrane with B7 |
Jul. 3, 2007 |
| 7232682 |
Expression vectors encoding epitopes of target-associated antigens and methods for their design |
Jun. 19, 2007 |
| 7229628 |
Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
Jun. 12, 2007 |
| 7226606 |
Cancer-associated antigens and methods of their identification and use |
Jun. 5, 2007 |
| 7217421 |
Cancer-associated antigens and methods of their identification and use |
May. 15, 2007 |
| 7205001 |
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
Apr. 17, 2007 |
| 7202334 |
Compositions and methods for the therapy and diagnosis of ovarian cancer |
Apr. 10, 2007 |
| 7179493 |
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
Feb. 20, 2007 |
| 7163703 |
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
Jan. 16, 2007 |
| 7160544 |
Method of vaccinating vertebrates |
Jan. 9, 2007 |
| 7160856 |
.alpha.-O-linked glycoconjugates, methods of preparation and uses thereof |
Jan. 9, 2007 |
| 7157091 |
MAGE-A1 peptides presented by HLA class II molecules |
Jan. 2, 2007 |
| 7147855 |
GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein |
Dec. 12, 2006 |
| 7144581 |
Compositions and methods for WT1 specific immunotherapy |
Dec. 5, 2006 |
| 7135188 |
Methods and compositions for immunotherapy of cancer |
Nov. 14, 2006 |
| 7132109 |
Using heat shock proteins to increase immune response |
Nov. 7, 2006 |
| 7118924 |
Method for producing human antibodies in SCID mice which uses dendritic cells pulsed with antigen-antibody complexes and antigen-antibody complexes as immunizing agents |
Oct. 10, 2006 |
| 7115272 |
Compositions and methods for WT1 specific immunotherapy |
Oct. 3, 2006 |
| 7109026 |
Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment |
Sep. 19, 2006 |
| 7105161 |
Proteinaceous adjuvants |
Sep. 12, 2006 |
| 7105155 |
Method and activated lymphocyte preparations for preventing recurrence of carcinoma |
Sep. 12, 2006 |
| 7105162 |
Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
Sep. 12, 2006 |
| 7098311 |
Fusion of jAZF1 and jjAZ1 genes in endometrial stromal tumors |
Aug. 29, 2006 |
| 7098306 |
Method and compositions for treating hepatocellular cancer |
Aug. 29, 2006 |
| 7097846 |
35 kD tumor associated protein antigen: uses and methods of detection |
Aug. 29, 2006 |
| 7063854 |
Composition and methods for WTI specific immunotherapy |
Jun. 20, 2006 |
|
|
|
